Researchers conducted the study at an academic tertiary referral center, identifying 4,214 patients with multidrug-resistant organism infections in a sterile site or bronchoalveolar lavage/bronchial wash culture. They also examined mortality and readmissions as well as the association of infectious diseases consultations with these outcomes.
The study shows infectious diseases consultations were significantly associated with reductions in 30-day and one-year mortality for resistant S. aureus and Enterobacteriaceae. It was also associated with reductions in 30-day mortality for polymicrobial infections. Infectious diseases consultations were associated with reduced 30-day readmission for resistant Enterobacteriaceae.
However, infectious diseases consultations were not associated with 30-day mortality reductions for Acinetobacter or Pseudomonas.
“Our results suggest that ID consultation may be beneficial for patients with some MDRO infections,” study authors concluded.
More articles on healthcare quality:
Heart failure patients admitted by geriatricians less likely to experience readmission: 7 study findings to know
3 ways interpersonal relationships influence preventative antibiotic treatment
Ohio DOH, Joint Commission investigating University Hospitals after fertility clinic incident
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
